IO Biotech Inc (NASDAQ:IOBT) — Market Cap & Net Worth
Market Cap & Net Worth: IO Biotech Inc (IOBT)
IO Biotech Inc (NASDAQ:IOBT) has a market capitalization of $611.57K ($611.57K) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30826 globally and #6162 in its home market, demonstrating a 150.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying IO Biotech Inc's stock price $0.01 by its total outstanding shares 71948842 (71.95 Million). Review IOBT total liabilities to assess the company's total debt and financial obligations.
IO Biotech Inc Market Cap History: 2021 to 2026
IO Biotech Inc's market capitalization history from 2021 to 2026. Data shows change from $460.47 Million to $611.57K (-80.55% CAGR).
Index Memberships
IO Biotech Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.00% | #913 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #2882 of 3165 |
Weight: IO Biotech Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
IO Biotech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how IO Biotech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of IOBT by Market Capitalization
Companies near IO Biotech Inc in the global market cap rankings as of August 3, 2026.
Key companies related to IO Biotech Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #424 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #543 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #563 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $477.10 |
| #424 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $762.63 |
| #543 | Argen-X | BR:ARGX | $49.55 Billion | €745.00 |
| #563 | UCB SA | BR:UCB | $47.34 Billion | €222.90 |
IO Biotech Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, IO Biotech Inc's market cap moved from $460.47 Million to $ 611.57K, with a yearly change of -80.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $611.57K | -98.60% |
| 2025 | $43.81 Million | -33.82% |
| 2024 | $66.19 Million | -51.06% |
| 2023 | $135.26 Million | -18.26% |
| 2022 | $165.48 Million | -64.06% |
| 2021 | $460.47 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 2nd, 2026 the market cap of IO Biotech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $611.57K USD |
| MoneyControl | $611.57K USD |
| MarketWatch | $611.57K USD |
| marketcap.company | $611.57K USD |
| Reuters | $611.57K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About IO Biotech Inc
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead therapeutic cancer vaccine candidate includes IO102-IO103, which targets cancer cells and immune-suppressive cells in the tumor microenvironment that express indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand … Read more